Virology tidbits

Virology tidbits

Monday, 10 November 2014

Beclin-1 and Viruses: Activation and Inhibition of Autophagy by Viral Proteins

Autophagy is an essential process that allows the degradation of cellular components such as damaged organelles (e.g. Mitochondria via mitophagy or Peroxisomes via pexophagy) or misfolded proteins, as well as bacteria or viral proteins. Generally, the initial step in autophagy is sequestering of organelles or proteins within the phagophore -an isolation membrane derived from the plasma membrane, ER, Golgi, or endosome. Following the formation of the phagophore the edges of the membrane are fused, forming a phagosome, a double membrane vesicle, that matures into the autophagosome and subsequently fuses with the lysosome to form the autolysosome. Therefore, the process can be divided into six steps, (1) Initiation, (2) Nucleation, (3) Elongation, (4) Closure, (5) Maturation, (6) Degradation.

This post will focus on the interaction of viral proteins with two steps -Initiation and Degradation-, in particular highlighting the role of the interaction of viral proteins with Beclin-1, using the M2 protein of Influenza A Virus and the coronaviral ER associated papain like protease (PLP-2/PLPro) as examples.


In mammalian cells not undergoing autophagy, Beclin-1 forms a complex with Bcl-2 and Bcl-xL at the ER, thus rendering Beclin-1 inactive. This complex however dissociates following phosphorylation of Beclin-1 by AMBRA1 or death-associated protein kinase (DAPK) at Thr-119 within the BH3-domain of Beclin-1 or phosphorylation of Bcl-2/Bcl-xL by c-Jun N-terminal kinase 1 (JNK1), thus allowing the formation of the phagophore by recruitment of Beclin-1 to Atg14L, Vps34, and Vps15/p150. This complex in turn recruits LC3-I - the non-lipidated form of LC-3- as well as a complex consisting of ATG5, ATG12, and ATG16L allowing the subsequent formation of LC3-I positive autophagic vesicles that mature into autophagosomes by lipidation of LC3-I in a process similar to ubiquitination. LC3-II positive vesicles subsequently fuse with the lysosome to form the autolysosome where the cargo is degraded by lysosomal enzymes. This process is not only dependent on  the Rab7, Rab8B and Rab24 GTPases, but also on Beclin-1 as cells deficient for Beclin-1 exhibit increased autophagic flux. While the RabGTPases -in particular Rab7- regulate the transport of mature autophagosomes to the lysosome via lysosome bound Rab7 that binds  to LC3-II  via FYCO, thus tethering lysosomes to autophagosomes and allowing the fusion of mature autophagosomes with lysosomes. In the case of Beclin-1 the precise mechanism is less clear.
Similar to the aforementioned process of initiating the formation of the autophagosome, in the case of facilitating the formation of the autolysosome, Beclin-1 forms a complex with Vps34 as well as Vps15, the latter anchoring the complex at the lysosome (similar to Rab7) . Different from the initiation complex however, instead of ATG14L, this complex contains UVRAG (UV radiation resistance-associated gene protein); indeed ATG14L and UVRAG bind Beclin-1 in mutually exclusive manner. Furthermore, a subpopulation of this complex associates with a negative regulator of autophagy, RUBICON (RUN domain and cysteine-rich domain containing, Beclin-1-interacting protein), thus leading to the existence of three different populations of Beclin-1 associated complexes, two which increase autophagic flux, one inhibiting autophagy.


Invitation of autophagosome formation and fusion with the lysosome involves Beclin-1
Complexes formed by Beclin-1

Viruses and Beclin-1: Influenza A Virus and Coronavirus

Activation of Beclin-1 and subsequent induction of autophagy by pathogens can be considered to be part of the innate immune response especially if the autophagic particle engulfs and degrades the infectious particle, as it is not only the case for bacteria but also for viruses such as Herpes Simplex Virus 1 (HSV 1). Consequently, all three subfamilies of the Herpesviridae encode for proteins that target Beclin-1, in the case of HSV 1 the ICP 34.5 protein, and thus inhibit autophagy by inhibiting the formation of the phagophore; indeed, in cells infected with a viral Δ ICP 34.5 mutant, HSV 1 particles are detectable in autophagosomes. In the case of positive strand RNA viruses however the inhibition of the formation of autophagosome might prevent the formation of the viral replication centers. In this case, some viral proteins may induce the formation of the phagophore whilst inhibiting the fusion with the lysosome and thus degradation of viral components (proteins and RNA). As discussed before, the coronaviral nsp-6 protein is an example and below recent results suggesting a similar role for the coronaviral PLP2/PLPro is discussed below.  In the case of Retroviridae, the HIV Nef protein has been demonstrated to block the fusion of the autophagosome with the lysosome and thus prevent the degradation of virions.


Influenza A Virus M2 protein: the more complex story

Influenza A Virus’ are negative strand RNA viruses, which utilise both the nucleus and the cytoplasm for its replication but autophagosome -or autophagosome like structures such as omegasomes-, are not used as replication centers in opposition to those induced positive strand RNA viruses. Following the infection of various cell lines including CV-1, MDCK, A549, and MEF cells with different strains of Influenza A Virus both of human and avian origin (A/Chicken/Beijing/04 (H9N2), A/PR8, and A/WSN/33), an increase in GFP-LC3 positive punctae can be observed concomitant with an increase in LC3-II levels, suggesting that the infection of (mammalian) cells with Influenza A induces the formation of mature autophagosomes. This increase in autophagy however does not result in an increase in autophagic flux since the application of a lysosome inhibitor -E64- does not increase LC3-II levels (although p62/SQSTM1 is degraded in infected primary human blood macrophages). Therefore, one or more proteins expressed by Influenza A has the capacity to induce autophagy but inhibit the fusion of the mature autophagosome with the lysosome. As discussed above, in uninfected cells this due to binding of Rubicon to Beclin-1 and indeed in cells infected with Influenza A virus the viral M2 and proteolytically cleaved HA proteins have been shown to prevent the fusion step in a similar manner, by binding to Beclin-1 (in the case o f M2 at least) independent of the ability to form proton channels. Paradoxically however, inhibiting the fusion of the autophagosome with the lysosome also induces apoptosis and it has been shown that in infected MEF cells autophagy is only induced when Bax mediated, mitochondrial, apoptotic pathways are blocked; the induction of autophagy and subsequent inhibition of the fusion of the autophagosome with the lysosome therefore represents an alternative cell death pathway, and inhibition of autophagy consequently does not increase viral titers. M2 however also binds LC3 via a LC3-Interacting domain (similar to optineurin or p62/SQSTM1) and relocates LC3 positive structures to the plasma membrane. These structures have been proposed to contain mature virions and contribute tot eh spread of (filamentous) Influenza A virus particles. Consequently, in the case of Influenza A virus, the expression of M2 is a mixed blessing: on one hand, it induces apoptosis independent of caspase activation via the mitochondrial pathway, on the other hand, it facilitates the spread of filamentous viral particles by interacting with LC3.  Since induction of M2 mediated autophagy can only be observed late in the infection, and M2 mediated apoptosis is only observed in BaxKO cells or cells treated with Caspase inhibitors, the predominant function of M2 regarding autophagy might be inducing the formation of mature autophagosomes containing filamentous virions, followed by preventing degradation of these and subsequent (re-)localisation of these to the cell surface via interaction with LC3 (personal opinion).



Influenza A Virus M2, Beclin-1, and LC3: induction of autophagy via biding to Beclin-1 and inhibition
fusion with the lysosome by binding to LC3 via M2-LIR

Coronavirus PLP2/PLPro, Beclin-1, and autophagy

As discussed in previous posts, the infection of cells with different members of the Coronaviridae as well as the expression of various coronaviral proteins -in particular the non-structural proteins nsp-3, -4, and -6 - induces the formation of double membrane vesicles (that form the coronaviral replication center) similar but distinct from autophagosomes. The precise mechanism of the formation of these vesicles is not known, although it has been shown that both nsp-3 and -4 have the ability to induce membrane curvature and that the EDEM-1 might play a role as well. In any case, these vesicles most likely do not represent mature autophagosomes but omegasomes (in the case of vesicles formed by nsp-6) or EDEMosomes; furthermore, the expression of nsp-6 inhibits the formation of mature lysosomes probably by inhibiting mTORC2 localisation to the lysosomal surface. In general however the requirement of the autophagic machinery for the replication of Coronavirus’ is still disputed since both Mouse Hepatitis Virus (MHV) and SARS-CoV replicate in primary ATG5-/- Mouse Embryonic Fibroblasts albeit with reduced viral titres.

As one of the non-structural proteins required for the formation of the RTCs and replication of the viral genome (for detailed review see previous posts here and here), the coronaviral genome encodes for nsp-3 which contains a membrane associated papain-like protease activity (PLP2-TM), whose main function is to cleave the viral orf1a polyprotein, generating a plethora of viral proteins, including nsp-4 and -6. 


MHV PLP2 is part of nsp-3

Intriguingly, PLP2 derived from various Coronavirus’, HCoV-NL63, Porcine Epidemic Diarrhoea Virus (PEDV), as well as the SARS-CoV PLPro, co-localise with LC3 in HEK293T, HeLa, as well as MCF-7 cells and increase the formation of LC3 positive punctae that resemble mature autophagosomes based on increased levels of LC3-II. These results indicate that the expression of PLP2 and PLPro respectively induces the formation of truly autophagic vesicles and further analysis showed that this process is independent of the catalytic activity of PLP2. As outlined above, the formation of the phagosome depends on the activation of Beclin-1 by dissociation of Beclin-1 from Bcl-2/Bcl-xL at the ER. In the case of PLP2, experimental data point towards the ability of PLP2 to bind Beclin-1 and thus promote the formation of the phagophore, although the domain responsible for such binding has not been identified. Rather than binding directly to Beclin-1, the author of this post favours a model where the expression of PLP2 (or PLPro in the case of SARS-CoV) induces the ER stress response with concomitant activation of JNK which then leads to the dissociation of Beclin-1 and subsequent induction of autophagy. The dissociation of Beclin-1 then allows the formation of a complex with PLP2/PLPro, a process that favours the formation of the autophagosomes -similar to the expression of Vacuole Membrane Protein 1 (VMP1).

The expression of PLP2 and PLPro not only leads to the accumulation of mature autophagosomes but also to decreased autophagic flux as measured by turnover of p62/SQSTM1. It has been proposed that the interaction of HCoV-NL63 PLP2 with Beclin-1 prevents the recruitment of lysosomes to the mature LC3-II positive autophagosome and thus the formation of the autolysosome, although a soluble form of PLP2 lacking the transmembrane domain fails to do so, indicating to the author of these lines that the transmembrane domain of PLP2 might be responsible for recruiting Beclin-1 and preventing the degradation of autophagosomes.


CoV PLP2 and Beclin-1: binding of Beclin-1 

Functionally, the association of PLP2 with Beclin-1 might prevent the induction of antiviral signalling namely inhibiting the activation of IRF3 via STING, although the precise mechanism is not known. Indeed expression of PLP2-TM in cells deficient for Beclin-1 fails to inhibit the Interferon response, suggesting that the induction of autophagy -albeit not leading to degradation- prevents antiviral signalling. It remains to be seen what the precise mechanism is, but the author of these lines favours a model in which the association of PLP2/PLPro with both STING and Beclin-1 triggers not only the formation of autophagosomes but also STING being localised to these autophagosomes. In other words, are the autophagosomes induced by PLP/PLPro expression also positive for STING?

CoV-PLP2, Beclin-1, and STING: sequestering of STING in autophagosomes?
Also it remains to be seen if the DUB domain of PLP2/PLPro is important for the induction of autophagy or if PLP2/PLPro or any other viral protein such as nsp-6 recruits Rubicon to autophagosomes. Also, is Beclin-1 being ubiquitinylated prior to associating with PLP/PLPro ?
As always, much to do and I hope that somebody is going to investigate these questions - or give me the opportunity and to do it.



Coronaviral proteins and autophagy: nsp-6 and PLP2 promote formation
of double membrane vesicles yet inhibit fusion with the lysosome


Interestingly, in the case of Influenza A Virus, the GFP-LC3 positive structures observed following the expression of M2 have been reported to accumulate in the perinuclear region prior to their transport to the plasma membrane. This raises the question if the inhibition of autophagosome-lysosome fusion by coronaviral proteins not only prevents the degradation of viral components as well as innate immune signalling but also ensures that the viral RTC can be transported to the ER-Golgi Intermediate Compartment and interact with the intracellular cargo receptor ERGIC-53.


ResearchBlogging.org







Further reading

Kang R, Zeh HJ, Lotze MT, & Tang D (2011). The Beclin 1 network regulates autophagy and apoptosis. Cell death and differentiation, 18 (4), 571-80 PMID: 21311563 

Ao X, Zou L, & Wu Y (2014). Regulation of autophagy by the Rab GTPase network. Cell death and differentiation, 21 (3), 348-58 PMID: 24440914 

Pankiv S, Alemu EA, Brech A, Bruun JA, Lamark T, Overvatn A, Bjørkøy G, & Johansen T (2010). FYCO1 is a Rab7 effector that binds to LC3 and PI3P to mediate microtubule plus end-directed vesicle transport. The Journal of cell biology, 188 (2), 253-69 PMID: 20100911 

Gu W, Wan D, Qian Q, Yi B, He Z, Gu Y, Wang L, & He S (2014). Ambra1 is an essential regulator of autophagy and apoptosis in SW620 cells: pro-survival role of Ambra1. PloS one, 9 (2) PMID: 24587252 

Zhong Y, Wang QJ, Li X, Yan Y, Backer JM, Chait BT, Heintz N, & Yue Z (2009). Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex. Nature cell biology, 11 (4), 468-76 PMID: 19270693

Matsunaga K, Saitoh T, Tabata K, Omori H, Satoh T, Kurotori N, Maejima I, Shirahama-Noda K, Ichimura T, Isobe T, Akira S, Noda T, & Yoshimori T (2009). Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nature cell biology, 11 (4), 385-96 PMID: 19270696 

Molejon MI, Ropolo A, Re AL, Boggio V, & Vaccaro MI (2013). The VMP1-Beclin 1 interaction regulates autophagy induction. Scientific reports, 3 PMID: 23316280 

Münz C (2011). Beclin-1 targeting for viral immune escape. Viruses, 3 (7), 1166-78 PMID: 21994775  

Dumit VI, & Dengjel J (2012). Autophagosomal protein dynamics and influenza virus infection. Frontiers in immunology, 3 PMID: 22566925 

Gannagé M, Dormann D, Albrecht R, Dengjel J, Torossi T, Rämer PC, Lee M, Strowig T, Arrey F, Conenello G, Pypaert M, Andersen J, García-Sastre A, & Münz C (2009). Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell host & microbe, 6 (4), 367-80 PMID: 19837376 

Hull JD, Gilmore R, & Lamb RA (1988). Integration of a small integral membrane protein, M2, of influenza virus into the endoplasmic reticulum: analysis of the internal signal-anchor domain of a protein with an ectoplasmic NH2 terminus. The Journal of cell biology, 106 (5), 1489-98 PMID: 2836432 

Zhirnov OP, & Klenk HD (2013). Influenza A virus proteins NS1 and hemagglutinin along with M2 are involved in stimulation of autophagy in infected cells. Journal of virology, 87 (24), 13107-14 PMID: 24027311
  
Law AH, Lee DC, Yuen KY, Peiris M, & Lau AS (2010). Cellular response to influenza virus infection: a potential role for autophagy in CXCL10 and interferon-alpha induction. Cellular & molecular immunology, 7 (4), 263-70 PMID: 20473322 

McLean JE, Datan E, Matassov D, & Zakeri ZF (2009). Lack of Bax prevents influenza A virus-induced apoptosis and causes diminished viral replication. Journal of virology, 83 (16), 8233-46 PMID: 19494020 

Beale R, Wise H, Stuart A, Ravenhill BJ, Digard P, & Randow F (2014). A LC3-interacting motif in the influenza A virus M2 protein is required to subvert autophagy and maintain virion stability. Cell host & microbe, 15 (2), 239-47 PMID: 24528869

Dumit VI, & Dengjel J (2012). Autophagosomal protein dynamics and influenza virus infection. Frontiers in immunology, 3 PMID: 22566925 

Maier HJ, & Britton P (2012). Involvement of autophagy in coronavirus replication. Viruses, 4 (12), 3440-51 PMID: 23202545 

Kanjanahaluethai A, Chen Z, Jukneliene D, & Baker SC (2007). Membrane topology of murine coronavirus replicase nonstructural protein 3. Virology, 361 (2), 391-401 PMID: 17222884 


Chen X, Wang K, Xing Y, Tu J, Yang X, Zhao Q, Li K, & Chen Z (2014). Coronavirus membrane-associated papain-like proteases induce autophagy through interacting with Beclin1 to negatively regulate antiviral innate immunity. Protein & cell PMID: 25311841

Tuesday, 14 October 2014

Marburg Virus and Keap1: induction of antioxidant response whilst inhibiting selective autophagy ?

Under normal conditions, Keap1 interacts with Nrf2 via the Nrf2-ECH homology domain 2 (Neh2) located within the N-terminal end of Nrf2 and ubiquitinates Nrf2 in a Cullin-3 dependent manner., leading to the proteasomal degradation of Nrf2 via the 26S proteasome independent of autophagy. Inactivation of Keap1 by binding p62/SQSTM1 via the C-terminal KELCH domain of Keap1 and the Keap1 interacting domain (KIR) of p62/SQSTM1 induces the degradation of Keap1 via selective autophagy, thus releasing Nrf2. In the case of oxidant independent activation of Nrf2, this translocation is preceded by phosphorylation of p62/SQSTM1 at Ser-351 of the KIR domain of p62/SQSTM1 whereas in the case of reactive oxygen species, nitric oxide, or electrophiles cysteine residues (Cys-151, Cys-273, and Cys-288 being the critical residues) of Keap1 are modified whereas Cadmium or Arsenic binds Keap1 at these residues while at the same time prevents Keap1 from interacting with p62/SQSTM1 and thus stabilising Keap1.


Domains of p62/SQSTM1/ Keap1, and Nrf2

Since both Keap1 and LC-3B are competing for binding to p62/SQSTM1 the ability of p62/SQSTM1 to form dimers with either NBR1 or with itself is crucial for the degradation of  p62/SQSTM1 complexes with Keap1 and ubiquitinylated proteins by selective autophagy; indeed, overexpression of mCherry-Keap1 has been shown to decrease the autophagic degradation of  p62/SQSTM1, but not abolish it, and endogenous as well overexpressed Keap1 co-localises with GFP-p62/SQSTM1 in p62/SQSTM1 and Ubiquitin  positive foci. 

Stabilised Nrf2 translocates to the nucleus where it forms a heterodimer with small musculoaponeurotic fibrosarcoma (MAF) proteins. This complex then binds to the Antioxidant response element (ARE) and thus induces the expression of cytoprotective genes, among them p62/SQSTM1 itself. Other target genes involve those in eliminating ROS (thioredoxin reductase1 and peroxiredoxin 1), detoxification of xenobiotics (NAD(P)H Dehydrogenase Quinone1, Glutathione S-Transferase), drug transport (multidrug resistance associated proteins), and glutathione synthesis (Glutamate-Cysteine Ligase). Regarding antiviral signalling, the infection of human alveolar epithelial cells with Influenza A/PR8 increases the production of ROS and thus activates the antioxidant response via the Keap1-Nrf2 pathway and thus increases the expression of ARE target genes inhibiting viral replication whilst being cytoprotective, in particular heme oxygenase -1 (HO-1), myxovirus resistance-1 (Mx1) and  2'-5'-oligoadenylate synthetase 1 (OAS1), in a Nrf2 dependent/Interferon independent manner.


The antioxidant response promotes selective autophagy by Nrf2 dependent upregulation of
p62/SQSTM1 expression and binding of Keap1 to p62/SQSTM1 as well as ubiquination of misfolded proteins 

Marburg (MARV) and Ebola (EBOV) VP24 and the antioxidant response pathway

Marburg (MARV) and Ebola (EBOV) viruses are both members of the Filoviridae, and are zoonotic viruses which utilize bats as a reservoir host species and cause highly fatal hemorrhagic fever in humans.  As mentioned in a previous post, the genomes of both MARV and EBOV are similar in structure, with both encoding for VP24, a multifunctional protein involved in viral RNA synthesis, formation of the viral nucleocapsid as well as the release of infectious viral particles. As such, VP24 derived from both MARV and EBOV localises in ring like structures in the cytoplasm of cells transfected with VP24 or infected with MARV or EBOV respectively, co-localising with viral RNA in infected cells. Accordingly, EBOV VP24 deletion mutants exhibit impaired viral replication due to impaired formation of the viral nucleocapsid, replication of the viral genome and increased interferon antiviral signalling. In contrast to EBOV VP24, MARV VP24 does not interact with Karyopherin-α and thus not block the translocation of tyrosine phosphorylated STAT-1 into the nucleus of infected cells.



MARV VP24 binds Keap1 and thus releases Nrf2 



Unlike EBOV VP24, MARV VP24 however does associate with Keap1 via the Kelch domain of both human and bat derived Keap1. Consequently, Nrf2 translocates into the nucleus where it activates genes under the control of the ARE element, including HO-1, NAD(P)H Dehydrogenase Quinone1 (NQO1) and Glutamate-cysteine ligase (GCLM). Interestingly, MARV VP24 does not upregulate the expression of p62/SQSTM1, whereas EBOV VP24 downregulates p62/SQSTM1 expression at 12 and 24 h p.i. , suggesting that both EBOV VP24 and MARV VP24 inhibit selective autophagy, allowing the accumulation of ubiquitinylated proteins. In the context of viral replication, in the opinion of the author of these lines, preventing the degradation of ubiquitinylated proteins via p62/SQSTM1 would prevent MARV VP40 from being degraded. MARV VP40 itself is required for viral budding, which is dependent on the ability of the PPPY motif to bind members of the HECT and/or Nedd4-like ubiquitin ligase. Therefore it might be possible that inhibiting selective autophagy by MARV VP24 might prevent the degradation of MARV VP40 and thus favours budding of the mature virions. Stabilising MARV VP40 by preventing autophagic degradation might also contribute to the inhibiting the Interferon signalling by inhibiting Jak1 signaling. Expression of MARV VP24 and subsequent induction of the antioxidant response pathway in the absence of inducing ROS might therefore not only prevent apoptosis but also inhibit antiviral signalling pathways. 


Model of inhibition of p62/SQSTM1 dependent autophagy by EBOV/MARV VP35 and/or MARV VP24 



In addition to VP40, both the EBOV and MARV VP35 proteins might inhibit selective, p62/SQSTM1 dependent, autophagy by preventing the phosphorylation of  p62/SQSTM1 at Ser403 via sequestering of TANK-Binding Kinase 1 (TBK1) since binding TBK1 by both EBOV and MARV VP35 has been implicated in inhibiting the phosphorylation of Interferon Regulatory Factor -3 (IRF-3).  If however, this interaction also inhibits or decreases the phosphorylation of p62/SQSTM1 at Ser403 and subsequently increases ubiquitin positive foci has not been demonstrated.

ResearchBlogging.org







Further reading 

Ishimura R, Tanaka K, & Komatsu M (2014). Dissection of the role of p62/Sqstm1 in activation of Nrf2 during xenophagy. FEBS letters, 588 (5), 822-8 PMID: 24492006 

Jain A, Lamark T, Sjøttem E, Larsen KB, Awuh JA, Øvervatn A, McMahon M, Hayes JD, & Johansen T (2010). p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. The Journal of biological chemistry, 285 (29), 22576-91 PMID: 20452972 

Fan W, Tang Z, Chen D, Moughon D, Ding X, Chen S, Zhu M, & Zhong Q (2010). Keap1 facilitates p62-mediated ubiquitin aggregate clearance via autophagy. Autophagy, 6 (5), 614-21 PMID: 20495340 

Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, Kim M, Nishito Y, Iemura S, Natsume T, Ueno T, Kominami E, Motohashi H, Tanaka K, & Yamamoto M (2010). The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nature cell biology, 12 (3), 213-23 PMID: 20173742

Amman BR, Carroll SA, Reed ZD, Sealy TK, Balinandi S, Swanepoel R, Kemp A, Erickson BR, Comer JA, Campbell S, Cannon DL, Khristova ML, Atimnedi P, Paddock CD, Crockett RJ, Flietstra TD, Warfield KL, Unfer R, Katongole-Mbidde E, Downing R, Tappero JW, Zaki SR, Rollin PE, Ksiazek TG, Nichol ST, & Towner JS (2012). Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS pathogens, 8 (10) PMID: 23055920 

Baird L, & Dinkova-Kostova AT (2011). The cytoprotective role of the Keap1-Nrf2 pathway. Archives of toxicology, 85 (4), 241-72 PMID: 21365312 

He X, & Ma Q (2010). Critical cysteine residues of Kelch-like ECH-associated protein 1 in arsenic sensing and suppression of nuclear factor erythroid 2-related factor 2. The Journal of pharmacology and experimental therapeutics, 332 (1), 66-75 PMID: 19808700 

Wu KC, Liu JJ, & Klaassen CD (2012). Nrf2 activation prevents cadmium-induced acute liver injury. Toxicology and applied pharmacology, 263 (1), 14-20 PMID: 22677785 Ma, Q. (2013). Role of Nrf2 in Oxidative Stress and Toxicity Annual Review of Pharmacology and Toxicology, 53 (1), 401-426 DOI: 10.1146/annurev-pharmtox-011112-140320 

Mateo M, Carbonnelle C, Martinez MJ, Reynard O, Page A, Volchkova VA, & Volchkov VE (2011). Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication. The Journal of infectious diseases, 204 Suppl 3 PMID: 21987766 

Mateo M, Reid SP, Leung LW, Basler CF, & Volchkov VE (2010). Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling. Journal of virology, 84 (2), 1169-75 PMID: 19889762 

Noda, T., Ebihara, H., Muramoto, Y., Fujii, K., Takada, A., Sagara, H., Kim, J., Kida, H., Feldmann, H., & Kawaoka, Y. (2006). Assembly and Budding of Ebolavirus PLoS Pathogens, 2 (9) DOI: 10.1371/journal.ppat.0020099 

Edwards MR, Johnson B, Mire CE, Xu W, Shabman RS, Speller LN, Leung DW, Geisbert TW, Amarasinghe GK, & Basler CF (2014). The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway. Cell reports, 6 (6), 1017-25 PMID: 24630991 

Bamberg S, Kolesnikova L, Möller P, Klenk HD, & Becker S (2005). VP24 of Marburg virus influences formation of infectious particles. Journal of virology, 79 (21), 13421-33 PMID: 16227263

Mateo M, Carbonnelle C, Martinez MJ, Reynard O, Page A, Volchkova VA, & Volchkov VE (2011). Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication. The Journal of infectious diseases, 204 Suppl 3 PMID: 21987766 

Urata S, Noda T, Kawaoka Y, Morikawa S, Yokosawa H, & Yasuda J (2007). Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP. Journal of virology, 81 (9), 4895-9 PMID: 17301151 

Martin-Serrano J, Eastman SW, Chung W, & Bieniasz PD (2005). HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. The Journal of cell biology, 168 (1), 89-101 PMID: 15623582 

Kosmider B, Messier EM, Janssen WJ, Nahreini P, Wang J, Hartshorn KL, & Mason RJ (2012). Nrf2 protects human alveolar epithelial cells against injury induced by influenza A virus. Respiratory research, 13 PMID: 22672594 

Niture SK, & Jaiswal AK (2011). Inhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosis. The Journal of biological chemistry, 286 (52), 44542-56 PMID: 22072718     

Prins KC, Cárdenas WB, & Basler CF (2009). Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. Journal of virology, 83 (7), 3069-77 PMID: 19153231 

Pilli M, Arko-Mensah J, Ponpuak M, Roberts E, Master S, Mandell MA, Dupont N, Ornatowski W, Jiang S, Bradfute SB, Bruun JA, Hansen TE, Johansen T, & Deretic V (2012). TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity, 37 (2), 223-34 PMID: 22921120